Newer studies have ascribed a role for merlin, a neurofibromatosis 2 (NF2)-related tumor suppressor in promotion of p53 stability and activity by inducing Mdm2 degradation in glioma cells [38]. The gene discussed is TP53; the disease is central nervous system cancer.